TrinityPoint Wealth’s Eli Lilly LLY Stock Holding History

TrinityPoint Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.24M	Sell	1,611 -89	-5%	-$73.7K	0.17%	134
2024 Q3	$1.51M	Sell	1,700 -120	-7%	-$108K	0.22%	108
2024 Q2	$1.65M	Buy	1,820 +23	+1%	+$18.4K	0.26%	99
2024 Q1	$1.4M	Buy	1,797 +20	+1%	+$14.2K	0.23%	101
2023 Q4	$1.04M	Sell	1,777 -9	-0.5%	-$5.25K	0.19%	125
2023 Q3	$959K	Buy	1,786 +437	+32%	+$225K	0.19%	119
2023 Q2	$633K	Buy	1,349 +109	+9%	+$45.7K	0.12%	155
2023 Q1	$426K	Buy	1,240 +6	+0.5%	+$2.02K	0.09%	188
2022 Q4	$451K	Buy	1,234 +15	+1%	+$5.32K	0.1%	179
2022 Q3	$394K	Buy	1,219 +26	+2%	+$8.24K	0.09%	177
2022 Q2	$387K	Hold	1,193	–	–	0.09%	192
2022 Q1	$342K	Hold	1,193	–	–	0.06%	226
2021 Q4	$329K	Hold	1,193	–	–	0.06%	241
2021 Q3	$276K	Buy	1,193 +109	+10%	+$26.9K	0.05%	255
2021 Q2	$249K	Hold	1,084	–	–	0.05%	237
2021 Q1	$203K	Buy	1,084 +17	+2%	+$3.33K	0.05%	234
2020 Q4	$227K	Buy	+1,067	New	+$159K	0.05%	211

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

TrinityPoint Wealth's LLY Position: Q4 2024 in Review

TrinityPoint Wealth reduced its Eli Lilly (LLY) stake by 5.2% in Q4 2024, selling an estimated $73.7K and leaving 1,611 shares worth $1.24M. The position accounts for 0.17% of the portfolio, ranked #134.

TrinityPoint Wealth first reported a position in LLY in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.65M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

TrinityPoint Wealth held 1,611 shares of Eli Lilly worth $1.24M as of Q4 2024.
TrinityPoint Wealth sold 89 Eli Lilly shares in Q4 2024, an estimated $73.7K.
Eli Lilly made up 0.17% of TrinityPoint Wealth's portfolio in Q4 2024, its #134 holding.
TrinityPoint Wealth first reported a position in Eli Lilly in Q4 2020 and has held it in 17 quarters since.
TrinityPoint Wealth's Eli Lilly position peaked at $1.65M in Q2 2024.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.